Skip to main content
. 2019 Nov 15;7:321. doi: 10.3389/fbioe.2019.00321

Figure 2.

Figure 2

Cell proliferation capacity in human IPFSCs after FN1-KO. FN1-KO cells were compared with copGFP in cell increase (A), percentage of cells in the S and G2 phases (B), and surface markers [SSEA4 (C), CD73 (D), CD90 (E), CD105 (F), and CD146 (G)] by flow cytometry; stemness genes (NANOG, SOX2, KLF4, BMI1, MYC, NOV, POU5F1, and NES) (H), senescent genes (CDKN1A, CDKN2A, and TP53) (I), and the mesenchymal condensation gene (CDH2) (J) by qPCR. GAPDH was used as an endogenous control. Data are shown as bar charts. * indicates a significant difference compared to the corresponding copGFP group (P < 0.05).